Kazuya Kitamura Selected Research

Sorafenib (BAY 43-9006)

2/2021	Safety and efficacy of sorafenib followed by regorafenib or lenvatinib in patients with hepatocellular carcinoma.
7/2020	Comparative analysis of liver functional reserve during lenvatinib and sorafenib for advanced hepatocellular carcinoma.
11/2018	Analysis of the liver functional reserve of patients with advanced hepatocellular carcinoma undergoing sorafenib treatment: Prospects for regorafenib therapy.
6/2016	Post-progression survival and progression-free survival in patients with advanced hepatocellular carcinoma treated by sorafenib.
1/2016	Potential efficacy of therapies targeting intrahepatic lesions after sorafenib treatment of patients with hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kazuya Kitamura Research Topics

Disease

13	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 09/2015
8	Neoplasms (Cancer) 02/2021 - 06/2002
7	Pathologic Constriction (Stenosis) 06/2022 - 12/2004
7	Spinal Cord Injuries (Spinal Cord Injury) 01/2020 - 08/2007
6	Spinal Cord Diseases 10/2022 - 03/2012
6	Colitis 01/2022 - 12/2004
6	Fibrosis (Cirrhosis) 08/2021 - 05/2002
6	Stomach Neoplasms (Stomach Cancer) 01/2021 - 06/2002
4	Lordosis 10/2022 - 01/2018
4	Inflammation (Inflammations) 01/2022 - 12/2004
4	Spinal Cord Compression 12/2018 - 01/2017
3	Kyphosis 10/2021 - 01/2018
3	Liver Cirrhosis (Hepatic Cirrhosis) 08/2021 - 05/2002
3	Crohn Disease (Crohn's Disease) 06/2020 - 12/2004
2	Non-alcoholic Fatty Liver Disease 08/2021 - 06/2019
2	Pain (Aches) 01/2021 - 03/2012
2	Neoplasm Metastasis (Metastasis) 10/2020 - 06/2002
2	Disease Progression 07/2019 - 06/2016
2	Pancreatic Neoplasms (Pancreatic Cancer) 04/2019 - 03/2008
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 09/2010 - 12/2004
2	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 07/2010 - 12/2004
1	Neck Pain (Cervicalgia) 03/2022
1	Dysbiosis 01/2022
1	Hepatitis 08/2021
1	Fatty Liver 08/2021
1	Ulcerative Colitis 08/2021
1	Hypophosphatemia 02/2021
1	Hemorrhage 01/2021
1	Thromboembolism 01/2021
1	Esophageal Neoplasms (Esophageal Cancer) 01/2021
1	Esophageal Stenosis (Esophageal Stricture) 01/2021
1	Fever (Fevers) 01/2021
1	Chronic Hepatitis C 10/2020
1	Tumor Lysis Syndrome 10/2020
1	Infections 10/2020
1	Melanoma (Melanoma, Malignant) 10/2020
1	Obstructive Jaundice (Cholestatic Jaundice) 01/2020
1	Sclerosing Cholangitis 01/2020
1	Thrombosis (Thrombus) 12/2019
1	Varicose Veins (Varicose Vein) 06/2019
1	Chronic Pancreatitis 04/2019
1	Neoplasms, Cystic, Mucinous, and Serous 04/2019

Drug/Important Bio-Agent (IBA)

5	Sorafenib (BAY 43-9006)FDA Link 02/2021 - 01/2016
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2020 - 05/2002
5	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2020 - 08/2007
4	Biomarkers (Surrogate Marker)IBA 08/2021 - 07/2004
4	CytokinesIBA 11/2019 - 12/2004
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 07/2004
2	Antiviral Agents (Antivirals)IBA 08/2021 - 06/2020
2	lenvatinibIBA 02/2021 - 07/2020
2	regorafenibIBA 02/2021 - 11/2018
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 01/2017
2	Nerve Growth Factors (Neurotrophins)IBA 01/2011 - 08/2007
2	LigandsIBA 09/2010 - 12/2004
2	Cadherins (E-Cadherin)IBA 07/2005 - 09/2004
2	retinoic acid receptor betaIBA 07/2005 - 09/2004
2	Tumor Biomarkers (Tumor Markers)IBA 07/2005 - 07/2004
2	CarbonIBA 11/2002 - 06/2002
1	rebamipideIBA 01/2022
1	SecretagoguesIBA 01/2022
1	MucinsIBA 01/2022
1	Long Noncoding RNAIBA 01/2022
1	Serum AlbuminIBA 08/2021
1	AlbuminsIBA 08/2021
1	Factor Xa InhibitorsIBA 01/2021
1	Talaporfin (talaporfin sodium)IBA 01/2021
1	AnticoagulantsIBA 01/2021
1	Dabigatran FDA Link 01/2021
1	Warfarin (Coumadin)FDA LinkGeneric 01/2021
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2021
1	InterferonsIBA 10/2020
1	Immune Checkpoint InhibitorsIBA 10/2020
1	NivolumabIBA 10/2020
1	gadolinium ethoxybenzyl DTPA FDA Link 06/2020
1	Immunologic Factors (Immunomodulators)IBA 06/2020
1	diethylenetriamineIBA 06/2020
1	GadoliniumIBA 06/2020
1	EpitopesIBA 01/2020
1	Fetal Proteins (Fetoprotein)IBA 01/2020
1	danaparoid (Orgaran)FDA Link 12/2019
1	Interleukin-10 (Interleukin 10)IBA 11/2019
1	Carrier Proteins (Binding Protein)IBA 06/2019
1	wisteria lectinIBA 06/2019
1	Aldo-Keto Reductase Family 1 member B10IBA 06/2019

Therapy/Procedure

15	Therapeutics 08/2021 - 03/2008
10	Laminectomy 10/2022 - 01/2017
6	Decompression 10/2022 - 01/2017
6	Drug Therapy (Chemotherapy) 10/2020 - 11/2002
4	Laminoplasty 04/2018 - 03/2012
3	Transplantation 11/2019 - 11/2009
2	Aftercare (After-Treatment) 06/2016 - 02/2008
1	Remission Induction 08/2021
1	Blood Component Removal (Apheresis) 08/2021
1	Plastic Surgery Procedures 05/2021
1	Lasers (Laser) 01/2021
1	Perioperative Period 01/2021
1	Chemoradiotherapy 01/2021
1	Photochemotherapy (Photodynamic Therapy) 01/2021
1	Immunotherapy 01/2020
1	Stents 01/2020